Ultra-low contrast percutaneous coronary intervention in advanced chronic kidney disease: from salvage technique to default strategy
University Clinical Hospital, University of Opole, Poland
- Chertow GM, Normand SL, McNeil BJ. „Renalism”: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 2004; 15: 2462-8.
- Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med 2019; 380: 2146-55.
- Jodlowski G, Ilnicki D, Osuch L, et al. Ultra-low contrast intravascular ultrasound-guided percutaneous coronary intervention of the left main and left anterior descending artery in advanced chronic kidney disease. Adv Interv Cardiol 2026; 22; in press.
- Gurm HS, Dixon SR, Smith DE, et al.; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011; 58: 907-14.
- Sacha J, Gierlotka M, Feusette P, Dudek D. Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review. Adv Interv Cardiol 2019; 15: 127-36.
- Shabbir A, Ali Z, Colletti G, et al. Ultra-low-contrast PCI: a structured approach to reducing dependence on contrast vessel opacification in PCI. JACC Cardiovasc Interv 2025; 18: 409-24.
- Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv 2014; 7: 1287-93.
- Sawant AC, Patel N, Pershad A. Safety, feasibility, and incremental value of ultralow and zero contrast PCI in an all-comers registry. Catheter Cardiovasc Interv 2024; 104: 648-54.
- Sacha J, Gierlotka M, Lipski P, et al. Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects. Adv Interv Cardiol 2019; 15: 137-42.
- Truong T, Boukhris M, Tuffreau-Martin AS, et al. Ultra-low contrast IVUS-guided PCI in patients with severe chronic kidney disease: an observational prospective study. Circ Cardiovasc Interv 2025; 18: e014854.
- Ahmed F, Ali R, Zulfiqar A, et al. Zero- and ultra-low-contrast percutaneous coronary intervention versus conventional PCI in advanced chronic kidney disease: a systematic review and meta-analysis. J. Cardio Renal Med 2026, 2: 3.
- Lee JM, Choi KH, Song YB, et al.; RENOVATE-COMPLEX-PCI Investigators. Intravascular imaging-guided or angiography-guided complex PCI. N Engl J Med 2023; 388: 1668-79.
- Weisbord SD, Gallagher M, Jneid H, et al.; PRESERVE Trial Group. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 2018; 378: 603-14.
- Brar SS, Aharonian V, Mansukhani P, et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 2014; 383: 1814-23.
- Badran AS, Gadelmawla AF, Khelifa H, et al. Evaluating zero-contrast transcatheter aortic valve implantation (TAVI) for patients with renal impairment: a pooled meta-analysis of 1505 patients. Catheter Cardiovasc Interv 2025; 106: 2147-59.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
